Us Bancorp \De\ Blueprint Medicines Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 11,971 shares of BPMC stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,971

Previous 4,834 147.64%

Holding current value

$1.15 Million

Previous $521,000 112.28%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$84.1 - $120.5 $600,221 - $860,008	7,137 Added 147.64%	11,971 $1.11 Million
Q2 2024 Aug 06, 2024	BUY	$85.18 - $108.78 $94,549 - $120,745	1,110 Added 29.81%	4,834 $521,000
Q1 2024 May 07, 2024	BUY	$73.17 - $99.79 $13,390 - $18,261	183 Added 5.17%	3,724 $353,000
Q4 2023 Feb 09, 2024	SELL	$43.96 - $92.84 $19,518 - $41,220	-444 Reduced 11.14%	3,541 $326,000
Q3 2023 Nov 03, 2023	SELL	$46.9 - $66.0 $8,629 - $12,144	-184 Reduced 4.41%	3,985 $200,000
Q2 2023 Aug 09, 2023	SELL	$42.2 - $66.37 $62,962 - $99,024	-1,492 Reduced 26.36%	4,169 $263,000
Q1 2023 May 09, 2023	SELL	$37.97 - $50.0 $108,062 - $142,300	-2,846 Reduced 33.45%	5,661 $254,000
Q4 2022 Feb 13, 2023	SELL	$41.06 - $66.48 $60,850 - $98,523	-1,482 Reduced 14.84%	8,507 $372,000
Q3 2022 Oct 27, 2022	BUY	$49.93 - $77.7 $136,209 - $211,965	2,728 Added 37.57%	9,989 $659,000
Q2 2022 Aug 01, 2022	BUY	$45.23 - $70.15 $1,221 - $1,894	27 Added 0.37%	7,261 $367,000
Q1 2022 May 11, 2022	BUY	$54.1 - $110.08 $40,196 - $81,789	743 Added 11.45%	7,234 $463,000
Q4 2021 Feb 11, 2022	BUY	$94.25 - $115.99 $112,817 - $138,840	1,197 Added 22.61%	6,491 $695,000
Q3 2021 Nov 10, 2021	BUY	$80.98 - $109.47 $42,514 - $57,471	525 Added 11.01%	5,294 $545,000
Q2 2021 Aug 05, 2021	BUY	$82.78 - $101.0 $17,466 - $21,311	211 Added 4.63%	4,769 $420,000
Q1 2021 Apr 28, 2021	BUY	$90.71 - $108.28 $389,871 - $465,387	4,298 Added 1653.08%	4,558 $442,000
Q4 2020 Feb 04, 2021	BUY	$92.08 - $124.48 $1,565 - $2,116	17 Added 7.0%	260 $29,000
Q3 2020 Nov 10, 2020	BUY	$66.45 - $92.7 $12,426 - $17,334	187 Added 333.93%	243 $23,000
Q2 2020 Aug 07, 2020	BUY	$57.09 - $79.27 $228 - $317	4 Added 7.69%	56 $4,000
Q1 2020 May 13, 2020	SELL	$48.11 - $82.22 $66,295 - $113,299	-1,378 Reduced 96.36%	52 $3,000
Q4 2019 Feb 04, 2020	BUY	$66.73 - $82.59 $31,696 - $39,230	475 Added 49.74%	1,430 $115,000
Q3 2019 Nov 08, 2019	BUY	$72.9 - $101.41 $20,922 - $29,104	287 Added 42.96%	955 $71,000
Q1 2019 May 08, 2019	BUY	$48.7 - $86.6 $9,740 - $17,320	200 Added 42.74%	668 $53,000
Q4 2018 Feb 13, 2019	BUY	$45.57 - $74.26 $10,070 - $16,411	221 Added 89.47%	468 $25,000
Q3 2018 Nov 01, 2018	BUY	$58.91 - $78.32 $11,016 - $14,645	187 Added 311.67%	247 $19,000
Q2 2018 Aug 08, 2018	BUY	$60.96 - $101.18 $792 - $1,315	13 Added 27.66%	60 $4,000
Q1 2018 May 08, 2018	SELL	$73.28 - $102.95 $14,656 - $20,590	-200 Reduced 80.97%	47 $4,000
Q3 2017 Nov 13, 2017	BUY	$42.37 - $69.67 $10,465 - $17,208	247	247 $17,000

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.76B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account